GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aap Implantate AAQ1.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

1.41

0.00%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Aap Implantate

Its shares trade on XETRA under the ticker AAQ1.DE. It has been listed since 10 May 1999. In the fiscal year to 31 December 2025, it reported revenue of €12.5m and a net loss of €2.6m. At that date it held total assets of €13.8m and shareholders' equity of €8.7m.

aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
10 May 1999
Employees
102
Website
aap.de ↗

Leadership

Pay as last reported

  • Mr. Rubino Di GirolamoChairman of the Board, Chief Executive Officer, since 2004€261,436
  • Dr. Nathalie KrebsChairwoman of the Supervisory Board, since 2019€50,000
  • Ms. Jacqueline RijsdijkDeputy Chairman of the Supervisory Board, since 2016€30,000
  • Ms. Agnieszka MierzejewskaChief Operating Officer, Member of the Management Board€217,178
  • Mr. Marc LangnerMember of the Supervisory Board€30,000
  • Mr. Torbjoern SkoeldMember of the Supervisory Board€12,500

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Aap Implantate AG possesses several strengths that provide a competitive advantage:

Weaknesses

  • Despite its strengths, Aap Implantate AG faces certain weaknesses that can hinder its growth:

Opportunities

  • Aap Implantate AG can leverage the following opportunities to enhance its market position:

Threats

  • Aap Implantate AG should be aware of the following threats that may impact its business:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.